DPH - Dechra Pharmaceuticals PLC
LSE
->
Healthcare
->
Drug Manufacturers—General
Northwich,
United Kingdom
Type: Equity
DPH price evolution
DPH
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $74.4 | $74.4 | $87.9 | $87.9 |
| Short term investments | ||||
| Net receivables | $169.6 | $169.6 | $147.6 | $147.6 |
| Inventory | $217.3 | $217.3 | $223.8 | $223.8 |
| Total current assets | $467.9 | $467.9 | $459.3 | $459.3 |
| Long term investments | $14.9 | $14.9 | $15.4 | $15.4 |
| Property, plant & equipment | $159.3 | $159.3 | $155.3 | $155.3 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1569.4 | $1569.4 | $1744.3 | $1744.3 |
| Current liabilities | ||||
| Accounts payable | $43.4 | $43.4 | $139.3 | $139.3 |
| Deferred revenue | ||||
| Short long term debt | $3.9 | $3.9 | $3.2 | $3.2 |
| Total current liabilities | $164 | $164 | $168.4 | $168.4 |
| Long term debt | $500.6 | $500.6 | $508 | $508 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $814.2 | $814.2 | $902.6 | $902.6 |
| Shareholders' equity | ||||
| Retained earnings | $86.6 | $86.6 | $151 | $151 |
| Other shareholder equity | $71.7 | $71.7 | $94.9 | $94.9 |
| Total shareholder equity | $755.2 | $755.2 | $841.7 | $841.7 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $74.4 | $120.9 | $118.4 | $454.8 |
| Short term investments | ||||
| Net receivables | $169.6 | $142.1 | $119.2 | $97.3 |
| Inventory | $217.3 | $175.7 | $149.5 | $120.8 |
| Total current assets | $467.9 | $444.4 | $392.2 | $448.9 |
| Long term investments | $14.9 | $15.8 | $17.1 | $17.4 |
| Property, plant & equipment | $159.3 | $100.3 | $87 | $76.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1569.4 | $1293.3 | $1214.1 | $1237.6 |
| Current liabilities | ||||
| Accounts payable | $43.4 | $46 | $35.2 | $34.6 |
| Deferred revenue | ||||
| Short long term debt | $3.9 | $3.3 | $3.1 | $4.6 |
| Total current liabilities | $164 | $158.7 | $155.8 | $137.3 |
| Long term debt | $500.6 | $325.8 | $317.6 | $353.1 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $814.2 | $626.5 | $581.2 | $600.1 |
| Shareholders' equity | ||||
| Retained earnings | $86.6 | $164 | $232.1 | $210.8 |
| Other shareholder equity | $71.7 | $87.8 | -$11.9 | $16.3 |
| Total shareholder equity | $755.2 | $666.8 | $632.9 | $637.5 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $192.05 | $192.05 | $188.7 | $188.7 |
| Cost of revenue | $86.5 | $86.5 | $79.45 | $79.45 |
| Gross Profit | $105.55 | $105.55 | $109.25 | $109.25 |
| Operating activities | ||||
| Research & development | $16.3 | $16.3 | $14.1 | $14.1 |
| Selling, general & administrative | $104.15 | $104.15 | $71.7 | $71.7 |
| Total operating expenses | $206.95 | $206.95 | $165.25 | $165.25 |
| Operating income | -$14.9 | -$14.9 | $23.45 | $23.45 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$7.65 | -$7.65 | $3.55 | $3.55 |
| Interest expense | -$6.9 | -$6.9 | -$4.65 | -$4.65 |
| Net income | ||||
| Net income | -$25.25 | -$25.25 | $11.3 | $11.3 |
| Income (for common shares) | -$25.25 | -$25.25 | $11.3 | $11.3 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $761.5 | $681.8 | $608 | $515.1 |
| Cost of revenue | $331.9 | $297 | $262.1 | $223.5 |
| Gross Profit | $429.6 | $384.8 | $345.9 | $291.6 |
| Operating activities | ||||
| Research & development | $60.8 | $36.1 | $32.4 | $28.4 |
| Selling, general & administrative | $351.7 | $252.9 | $151.3 | $134.9 |
| Total operating expenses | $744.4 | $586 | $521.2 | $465.4 |
| Operating income | $17.1 | $95.8 | $86.8 | $49.7 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$8.2 | $19.4 | $18.5 | $7 |
| Interest expense | -$23.1 | -$8.8 | ||
| Net income | ||||
| Net income | -$27.9 | $58.2 | $55.5 | $33.9 |
| Income (for common shares) | -$27.9 | $58.2 | $55.5 | $33.9 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Net income | -$25.25 | -$25.25 | $11.3 | $11.3 |
| Operating activities | ||||
| Depreciation | $20.55 | $3.75 | $3.1 | $3.1 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $6.05 | $6.05 | $25.75 | $25.75 |
| Investing activities | ||||
| Capital expenditures | -$6.15 | -$6.15 | -$5.25 | -$5.25 |
| Investments | ||||
| Total cash flows from investing | -$9 | -$9 | -$204.1 | -$204.1 |
| Financing activities | ||||
| Dividends paid | -$7.15 | -$7.15 | -$18.7 | -$18.7 |
| Sale and purchase of stock | $0.55 | $0.55 | $90.4 | $90.4 |
| Net borrowings | $4.15 | $4.15 | $89 | $89 |
| Total cash flows from financing | -$2.45 | -$2.45 | $160.7 | $160.7 |
| Effect of exchange rate | $0.75 | $0.75 | $0.35 | $0.35 |
| Change in cash and equivalents | -$6.75 | -$6.75 | -$16.5 | -$16.5 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Net income | -$27.9 | $58.2 | $84 | $52.2 |
| Operating activities | ||||
| Depreciation | $49.7 | $11.1 | $11 | $9.9 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $63.6 | $122.9 | $89.1 | $106.4 |
| Investing activities | ||||
| Capital expenditures | -$22.8 | -$20.3 | -$134.8 | -$49.2 |
| Investments | ||||
| Total cash flows from investing | -$426.2 | -$78.3 | -$136.1 | -$81.5 |
| Financing activities | ||||
| Dividends paid | -$51.7 | -$44.8 | -$37.9 | -$33.3 |
| Sale and purchase of stock | $181.9 | $2.3 | $2.3 | $131.5 |
| Net borrowings | $186.3 | -$3.6 | -$19.5 | $22.4 |
| Total cash flows from financing | $316.5 | -$46.1 | -$55.1 | $118.9 |
| Effect of exchange rate | $2.2 | -$4.5 | -$6.9 | $3.3 |
| Change in cash and equivalents | -$46.5 | $2.5 | -$109 | $147.1 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $761.50M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$27.90M |
| Revenue Q/Q | 9.93% |
| Revenue Y/Y | -23.08% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -1.68% |
| ROE | -3.49% |
| Debt/Equity | 1.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.85 |
| Quick ratio | 1.53 |